Shwachman Diamond Syndrome Registry and Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBoston Children's Hospital

About this trial

Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse regarding the clinical features, natural history, clinical outcomes with current management, and treatment. For this reason, the SDS Registry was formed to collect clinical data from medical records and to bank biological samples with the goal of understanding SDS/SDS-Like diseases to develop better treatments and improve the health of patients with these conditions.

Eligibility criteria

Qualifiers

Biallelic mutations in SBDS, or pathogenic mutations in DNAJC21, EFL1, or SRP54 OR

Shwachman-Diamond Syndrome defined clinically OR

Clinically suspected Shwachman-Diamond Syndrome OR

Phenotypic features suggestive of SDS OR

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Boston Children's Hospital

Lead sponsor

Children's Hospital Medical Center, Cincinnati

Collaborator